Modulation of lymphocytic infiltrates in C4 mouse mammary tumors.
Wei
W Z
WZ
Department of Immunology, Michigan Cancer Foundation, Detroit 48201.
Fulton
A
A
Malone
K
K
Heppner
G
G
D000818:Animals; D002465:Cell Movement; D015232:Dinoprostone / Q000502:physiology; D005260:Female; D006965:Hyperplasia; D007213:Indomethacin / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D008321:Mammary Glands, Animal / Q000473:pathology / Q000637:transplantation; D008325:Mammary Neoplasms, Experimental / Q000473:pathology / Q000517:prevention & control / Q000628:therapy*; D051379:Mice; D011230:Precancerous Conditions / Q000473:pathology; D011994:Recombinant Proteins / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000145:classification / Q000473:pathology*
D007376:Interleukin-2; D011994:Recombinant Proteins; D015232:Dinoprostone; D007213:Indomethacin